Company Profile Scottish Biomedical is a pre-clinical drug discovery services company focussing exclusively on early stage drug research.
Key service areas - Phosphodiesterase Drug Discovery Services
- Ion Channel Services
Scottish Biomedical utilises its expertise in cell systems biology and medicinal chemistry to establish successful drug discovery collaborations with pharmaceutical and biotech clients worldwide.
In some of the company's collaborations, Scottish Biomedical is tasked with identifying and validating drug targets or discovering lead molecules, in others we carry programmes right through to the development candidate stage. Our flexible/modular approach enables drug discovery collaborations to be tailored to meet the specific requirements of our clients.
Established in 1994, Scottish Biomedical is a private, self-funded drug discovery services company located on the West of Scotland Science Park, Glasgow, Scotland. Our capabilities and expertise are in the areas of ethical tissue acquisition, molecular biology, protein technology, primary & secondary assay development, high-throughput & high-content screening, medicinal chemistry and pharmacology. Scottish Biomedical's scientists are experts in signal transduction. We routinely draw upon our expertise in intracellular signalling and understanding of how a specific target interacts and functions in the cellular environment to enable us to identify desirable characteristics of drug targets and candidates. Services Overview Areas of Activity - Tissue Acquisition
- Molecular Biology
- Protein Technology
- Screening
- Cell Biology
- Medicinal Chemistry
- Pharmacology
| 
